SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Surging Treasury yields and a global bond selloff are fueling concern that higher borrowing costs and possible Fed hikes could pressure equities. Traders are divided between bearish warnings about a broader selloff and bulls viewing sharp rebounds as buying opportunities, with cooler inflation and strong Micron results cited as counterpoints.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns blowout results and stronger outlook, driven by AI-related memory demand and tight supply, are drawing attention, but the stocks muted reaction has surprised many traders. Bulls see the outlook and continued supply constraints as support for further growth, while skeptics point to high expectations, rising capex, Treasury yields and memory-cycle risks; options traders also lament the flat move and volatility decay.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A global bond selloff and rising Treasury yields are fueling concern about pressure on QQQs growth-heavy holdings, even as the index repeatedly rebounds. Traders are divided over whether AI and semiconductor strength, including optimism after Microns report, can sustain the rally or whether higher rates and broader macro risks will weigh on it.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields reach multi-decade highs, with traders pointing to persistent inflation concerns, strong growth, and government debt as reasons yields may stay elevated. The discussion is largely bearish on the ETFs continued selloff, though some traders see oversold conditions and are accumulating in anticipation of a rebound.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nikes upcoming fiscal Q1 earnings have traders focused on whether results and guidance can show progress in the turnaround, as the shares trade near multiyear lows. The community is split between bearish views citing weak demand, China and competition, and contrarian bets on a recovery or short squeeze amid elevated short interest.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is drawing attention after Panasonic Advanced Technology, Jasmy and JANCTION described a working Smart Render product using distributed GPUs, with plans for commercial use. Traders welcomed the tangible development, while some questioned whether it will create direct demand for JASMY or translate into adoption amid concerns about exchange delistings.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Googles Gemini 4 Argon launch, focused on coding and cybersecurity, is driving attention as traders debate whether it can bolster Alphabets position in the AI race. Enthusiasm over the models capabilities is tempered by complaints that the stocks initial gains faded and by broader concerns about competition from Meta and other AI developers.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Rising Treasury yields and persistent rate-hike concerns are weighing on the rate-sensitive small-cap Russell 2000, which traders say is underperforming large-cap tech as borrowing and refinancing costs pressure smaller companies. The community is divided between bearish calls for further weakness and hopes for an oversold bounce near the 200-day moving average, with some pointing to cooler PCE data as potential relief.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Bullish analyst calls and CoreWeaves AI-cloud expansion updates are fueling discussion about demand for AI compute. Traders cite strong demand and pricing potential, while skeptics point to heavy capex, debt and dilutionand frustration that the stock repeatedly struggles to hold gains.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentums strong results, upbeat outlook and comments about rising AI-optics orders are reinforcing the view that it benefits from growing data-center connectivity demand. Traders remain divided between the growth story and concerns about its rich valuation, with sharp swings prompting both breakout bets and profit-taking or short positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shredding Pounds, Trading Stocks—Lilly’s Potential Obesity Blockbuster and other Biotechs in Play

The biotech tape is entering a catalyst-heavy stretch, with NeOnc Technologies Holdings (NASDAQ:NTHI), Connect Biopharma (NASDAQ:CNTB), Valion Bio (NASDAQ:VBIO), Eli Lilly and Company (NYSE:LLY), Celcuity (NASDAQ:CELC), and Capricor Therapeutics (NASDAQ:CAPR) heading into important stretches, but for very different reasons.

Connect Biopharma’s COPD Data Could Put Rademikibart on the Fast Track to Phase 3

Connect Biopharma (NASDAQ:CNTB) delivered a potentially important clinical catalyst today, announcing positive preliminary topline results from its global Phase 2 Seabreeze STAT COPD study evaluating rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation. The company reported an 81% reduction in treatment failure, an 85% reduction in new moderate-to-severe COPD exacerbations, and a 100% reduction in new emergency-department visits or hospitalizations for new exacerbations through four weeks versus placebo, with statistically significant p-values for all three measures. Rademikibart was also reported to have been well tolerated, with fewer adverse events and serious adverse events than placebo and no new safety signals.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday's pre-market session.
Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 79.43% to $1.78. The market value ofread more...

Connect Biopharma Advances Rademikibart Toward Phase 3 In COPD

(RTTNews) - Wednesday, Connect Biopharma Holdings (CNTB) reported positive topline results from a global Phase 2 study of rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation...

BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB

BML Capital Management LLC lowered its holdings in shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 67.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owne...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assig...

Northland Securities Weighs in on CNTB Q1 Earnings

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Connect...

Q1 Earnings Estimate for CNTB Issued By HC Wainwright

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Connect Biopharma in a research note issued on Wednesday, April 8th. HC Wainwright analyst B. Folkes expects that the company will post...

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are currently...

Connect Biopharma (NASDAQ:CNTB) Director Buys $4,002,000.00 in Stock

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang acquired 1,160,000 shares of Connect Biopharma stock in a transaction that occurred on Tuesday...

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

Connect Biopharma Holdings Ltd

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.10
Prev Close	$0.992
Open	$1.89
Dividend Yield	0.00%
50-Day Moving Average	$1.95
Beta	0.64
Avg. Volume	450,726.81
PE Ratio	-0.92

52-Week High	$3.82
52-Week Low	$0.98
Market Capitalization	$62.47M
EPS (Annual)	-$0.9968
Price to Book	2.58
Revenue Per Employee	$1,000.00

Feed

News

Sentiment

Fundamentals

Info

CNTB Fundamentals